Category: Uncategorized

CATALUNYA BIOPHARMA CAPITAL GROUP AT LINKEDIN" "" "Dear Members" "" "Some of you may find this group a useful adjunct. There are likely good opportunities for partnerships, mentoring, jobs, investment, and much more. Come and find out how dynamic Catalunya is! We need advice, observations and input about an emerging biopharma sector in northern Spain that has all the ingredients to become a next Silicon Valley for entrepreneuring. " "" "Thank you. View in LinkedIn

HANG ONTO YOUR SEATS!" "" "We will announce in the New Year a new company in Barcelona dedicated to solving these problems. We will also have a survey of members completed in the coming weeks so you can all see your thoughts. Watch this space!! View in LinkedIn

CATALUNYA BIOPHARMA CAPITAL GROUP AT LINKEDIN" "" "Dear Members: Catalunya in Northern Spain is emerging as a new Silicon Valley for entrepreneuring, with opportunities for partnering, mentoring, investing and much more. This may be a useful adjunct to this group. Please come and see how dynamic the region is, and especially, we are interested in your observations about how to grow the industry. Your historical insights would be invaluable. View in LinkedIn

OBVIOUS LOGIC" "" "The other obvious point is this: there is duplication among the young biopharma companies, and like any maturing industry, mergers, acquisitions, strategic alliances and collaborations are critical. I have not seen a lot of companies thinking seriously about this. The time is now! View in LinkedIn

SIMPLE FACT: CAPITAL SHORTFALL" "" "Somebody has probably done the precise calculation but this is a simple back of the envelope estimation: there are (by Biocat's figuring) about 91 biotech and 71 pharma companies in Catalunya. This is 162 companies in this sector. Assuming a very rough $25 M in clinical trial costs to get to Phase II Proof-of-Concept, this a capital need of about $4.0 billion. The capital available in Catalan VC companies is probably no more than 200-300 M, optimistically. The delta is huge. Without external capital, most of these small biopharma companies will not survive. View in LinkedIn

PLEASE INVITE STAKEHOLDER NOT YET REPRESENTED" "" "Dear members. Please invite any stateholders in the Catalan biopharma industry who you may know so we can include their views. At some point quite soon, I will try and summarize some of the key comments raised, and issue to everyone a small survey to obtain some data from stakeholders, to get a poll of your views. View in LinkedIn

CATALUNYA BIOPHARMA CAPITAL GROUP ON LINKEDIN" "" "Dear Members: Catalunya in Northern Spain is emerging as a new Silicon Valley for entrepreneuring, with opportunities for partnering, mentoring, investing and much more. This may be a useful adjunct to this group. Please come and see how dynamic the region is, and especially, we are interested in your observations about how to grow the industry. Your historical insights would be invaluable. View in LinkedIn

YOU CAN TEACH THE WORLD HOW TO START A BIOPHARMA SECTOR! PLEASE TEACH CATALUNYA HOW TO DO IT!" "" "Dear members: WE NEED YOUR EXPERT ADVICE! You have had great success figuring out how to start a biopharma industry in your country. The area of Northern Spain known as Catalunya is a new emerging Silicon Valley for biopharma companies and the statistics are impressive. Please come and join our group and teach us!" "" "The Linkedin group is called CATALUNYA BIOPHARMA CAPITAL." "" "There are opportunities for consulting, partnership, and much more. View in LinkedIn

CATALUNYA BIOPHARMA CAPITAL GROUP AT LINKEDIN" "" "Dear Members" "" "Some of you may find this group a useful adjunct. There are likely good opportunities for partnerships, mentoring, jobs, investment, and much more. Come and find out how dynamic Catalunya is! We need advice, observations and input about an emerging biopharma sector in northern Spain that has all the ingredients to become a next Silicon Valley for entrepreneuring. " "" "Thank you." "" "Nigel View in LinkedIn

KEY ISSUES TO FIGURE OUT" "" "1. Define the problems facing Catalan biopharmas trying to find funding today" "" "2. List the lessons of other countries in their early days of setting up biopharma industries, and how they overcame their problems" "" "3. Identify any new lessons from the mature biopharma sectors today that can apply to an emerging industry in Catalunya View in LinkedIn